Patent details

Basic Information

Publication number:

93092

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP078023488

Legal Status:

Inactive

Application number:

93092

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/869 - Lemtrada - alemtuzumab

Marketing Authorization Type:

Marketing Authorization Date:

16/09/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

31/05/2016

First Marketing Authorization date:

16/09/2013

Grant date:

01/08/2016

Activation date:

Publication date:

01/08/2016

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

16/09/2028

SPC Extension Expiration:

16/09/2028

Rejection date:

Withdrawal date:

Owner

From:

31/05/2016

 

 

Name:

Alcafleu Management GmbH & Co. KG

Address:

Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf, Germany (DE)

Name:

Genzyme Corporation

Address:

500 Kendall Street, Cambridge, MA 02142, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

31/05/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MARGOLIN David Harris

Address:

United States (US)

2

Name:

SACHSE Andreas

Address:

Germany (DE)

Annual Fees

Annual Fee Due Date:

30/09/2027

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages